Pharma Grade Sodium Bicarbonate Industry Size, Share & Demand

According to Future Market Insights (FMI), the worldwide pharma-grade sodium bicarbonate market share is expected to reach USD 274.8 million in 2024 and USD 387.7 million by 2034. The market is projected to rise at a CAGR of 3.5% by 2034.

The global pharma-grade sodium bicarbonate market is driven by the increasing consumption of sodium bicarbonate by the pharmaceutical industry, particularly as an active pharmaceutical ingredient (API). It is widely used in treating metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal blood circulation, and uncontrolled diabetes.

Growing geriatric population is set to drive demand for sodium-based medications. API is expected to become the dominant chief ingredient in drug

Only people mentioned by futurechemical in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Future Insights, click on at the bottom under it